Oncology | Pathology Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. July 24, 2024
Biomedical Engineering | Oncology | Pathology Label-Free Virtual HER2 Immunohistochemical Staining of Breast Tissue using Deep Learning. October 18, 2023
Oncology | Radiology Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer. August 19, 2023
Oncology | Pathology Weakly supervised bilayer convolutional network in segmentation of HER2 related cells to guide HER2 targeted therapies. August 3, 2023
Oncology | Pathology | Precision Medicine Detection of ERBB2 and CEN17 signals in fluorescent in situ hybridization and dual in situ hybridization for guiding breast cancer HER2 target therapy. June 9, 2023
Oncology | Radiology Deep learning for predicting the human epidermal growth factor receptor 2 status of breast cancer liver metastases based on contrast-enhanced computed tomography: a development and validation study. May 14, 2023
Oncology | Pathology Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning. January 21, 2023
Oncology | Pathology Strategies for Enhancing the Multi-Stage Classification Performances of HER2 Breast Cancer from Hematoxylin and Eosin Images. November 26, 2022
Deep Learning | Oncology | Pathology Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry. October 17, 2022
Neurology | Oncology | Radiology A deep learning approach with subregion partition in MRI image analysis for metastatic brain tumor. August 22, 2022
Oncology | Radiology Predicting HER2 Status in Breast Cancer on Ultrasound Images Using Deep Learning Method. March 7, 2022
Oncology | Pathology Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer. September 8, 2021